These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7864905)
21. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436 [TBL] [Abstract][Full Text] [Related]
22. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Wallaschofski H; Kuwert T; Lohmann T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319 [TBL] [Abstract][Full Text] [Related]
23. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
24. Scanning immuno-electron microscopy of a monoclonal, Epstein-Barr Virus(EBV) transformed human cell line producing rheumatoid factor in-vitro. Gamliel H; Steinitz M; Neeman Z; Polliack A Scan Electron Microsc; 1983; (Pt 1):271-8. PubMed ID: 6314493 [TBL] [Abstract][Full Text] [Related]
25. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. Zakarija M J Clin Lab Immunol; 1983 Feb; 10(2):77-85. PubMed ID: 6133001 [TBL] [Abstract][Full Text] [Related]
26. Thyroid antibodies are produced by thyroid-derived lymphocytes. Weetman AP; McGregor AM; Lazarus JH; Hall R Clin Exp Immunol; 1982 Apr; 48(1):196-200. PubMed ID: 7044629 [TBL] [Abstract][Full Text] [Related]
27. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039 [TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. Okuda J; Akamizu T; Sugawa H; Matsuda F; Hua L; Mori T J Clin Endocrinol Metab; 1994 Dec; 79(6):1600-4. PubMed ID: 7989462 [TBL] [Abstract][Full Text] [Related]
30. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease. Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516 [TBL] [Abstract][Full Text] [Related]
31. Recombinant monoclonal thyrotropin-stimulation blocking antibody (TSBAb) established from peripheral lymphocytes of a hypothyroid patient with primary myxedema. Moriyama K; Okuda J; Saijo M; Hattori Y; Kanamoto N; Hataya Y; Matsuda F; Mori T; Nakao K; Akamizu T J Endocrinol Invest; 2003 Nov; 26(11):1076-80. PubMed ID: 15008244 [TBL] [Abstract][Full Text] [Related]
32. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS). Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747 [TBL] [Abstract][Full Text] [Related]
33. Transformation of human colostrum lymphocytes with Epstein-Barr virus. Shinmoto H; Dosako S; Tanaka S Tokai J Exp Clin Med; 1992 Oct; 17(3-4):129-32. PubMed ID: 1338659 [TBL] [Abstract][Full Text] [Related]
35. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. Rosén A; Persson K; Klein G J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902 [TBL] [Abstract][Full Text] [Related]
36. Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators. Ealey PA; Kohn LD; Ekins RP; Marshall NJ J Clin Endocrinol Metab; 1984 May; 58(5):909-14. PubMed ID: 6546765 [TBL] [Abstract][Full Text] [Related]
37. Neutralization and purification of thyroid stimulating antibody (TSAb) and thyroid blocking antibody (TBAb) by heterophilic antibody to animal IgG in Graves' disease. Ochi Y; Kajita Y; Hachiya T; Hamaoki M Endocr J; 2012; 59(1):65-72. PubMed ID: 22082836 [TBL] [Abstract][Full Text] [Related]
38. Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas. Thompson KM; Melamed MD; Eagle K; Gorick BD; Gibson T; Holburn AM; Hughes-Jones NC Immunology; 1986 May; 58(1):157-60. PubMed ID: 3011653 [TBL] [Abstract][Full Text] [Related]
39. The influence of Epstein-Barr virus reactivation in patients with Graves' disease. Nagata K; Fukata S; Kanai K; Satoh Y; Segawa T; Kuwamoto S; Sugihara H; Kato M; Murakami I; Hayashi K; Sairenji T Viral Immunol; 2011 Apr; 24(2):143-9. PubMed ID: 21449724 [TBL] [Abstract][Full Text] [Related]
40. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients. Lundgren K; Wahlgren M; Troye-Blomberg M; Berzins K; Perlmann H; Perlmann P J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]